Overview
The primary aims of this mixed-methods trial are to test the feasibility and acceptability of the novel Cognitive Strategies, Mindfulness, and Rehabilitation Therapy (C-SMART) delivered via telehealth to patients with primary brain tumors and mild neurocognitive disorder (mNCD).
Eligibility
Inclusion Criteria:
- Adults with a primary brain tumor confirmed by histology or neuro-oncologist's report
- At least one domain of neurocognitive function ≥ 1.5 SD below estimate premorbid functioning or ≥ 1.5 SD below population mean
- Karnofsky's Performance Status (KPS) score > 40
- ≥ 1 month out of radiation therapy
- Ability to read, speak, and understand English
Exclusion Criteria:
- Inability to attend virtual sessions
- Inability to understand and provide informed consent
- Presence of clinically significant insomnia